Accéder au contenu
Merck
Toutes les photos(1)

Key Documents

P2939000

Prilocaine

European Pharmacopoeia (EP) Reference Standard

Synonyme(s) :

(±)-2′-Methyl-2-(propylamino)propionanilide, N-(2-Methylphenyl)-2-(propylamino)propanamide

Se connecterpour consulter vos tarifs contractuels et ceux de votre entreprise/organisme
Toutes les photos(1)

About This Item

Formule empirique (notation de Hill):
C13H20N2O
Numéro CAS:
721-50-6
Poids moléculaire :
220.31
Code UNSPSC :
41116107
Nomenclature NACRES :
NA.24

Qualité

pharmaceutical primary standard

Famille d'API

prilocaine

Fabricant/nom de marque

EDQM

Application(s)

pharmaceutical (small molecule)

Format

neat

Température de stockage

2-8°C

InChI

1S/C13H20N2O/c1-4-9-14-11(3)13(16)15-12-8-6-5-7-10(12)2/h5-8,11,14H,4,9H2,1-3H3,(H,15,16)

Clé InChI

MVFGUOIZUNYYSO-UHFFFAOYSA-N

Vous recherchez des produits similaires ? Visite Guide de comparaison des produits

Description générale

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the Issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia.

Application

Prilocaine EP Reference standard, intended for use in laboratory tests only as specifically prescribed in the European Pharmacopoeia.

Conditionnement

The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.

Autres remarques

Sales restrictions may apply.

Produit(s) apparenté(s)

Réf. du produit
Description
Tarif

1561019

Prilocaine Related Compound A, United States Pharmacopeia (USP) Reference Standard

P2939025

Prilocaine impurity E, European Pharmacopoeia (EP) Reference Standard

P2939060

Prilocaine hydrochloride, European Pharmacopoeia (EP) Reference Standard

Y0001408

Prilocaine impurity B, European Pharmacopoeia (EP) Reference Standard

1561008

Prilocaine hydrochloride, United States Pharmacopeia (USP) Reference Standard

1561020

Prilocaine Related Compound B, United States Pharmacopeia (USP) Reference Standard

1560990

Prilocaine, United States Pharmacopeia (USP) Reference Standard

Y0001681

Prilocaine for peak identification, European Pharmacopoeia (EP) Reference Standard

BP497

Prilocaine hydrochloride, British Pharmacopoeia (BP) Reference Standard

PHR3105

Prilocaine, pharmaceutical secondary standard, certified reference material

PHR3106

Prilocaine Hydrochloride, pharmaceutical secondary standard, certified reference material

PHR3107

Prilocaine Related Compound A, pharmaceutical secondary standard, certified reference material

Pictogrammes

Exclamation mark
GHS07

Mention d'avertissement

Warning

Mentions de danger

H302,H319

Classification des risques

Acute Tox. 4 Oral - Eye Irrit. 2

Code de la classe de stockage

11 - Combustible Solids

Classe de danger pour l'eau (WGK)

WGK 3

Faites votre choix parmi les versions les plus récentes :

Certificats d'analyse (COA)

Lot/Batch Number

Désolés, nous n'avons pas de COA pour ce produit disponible en ligne pour le moment.

Si vous avez besoin d'assistance, veuillez contacter Service Clients

Déjà en possession de ce produit ?

Retrouvez la documentation relative aux produits que vous avez récemment achetés dans la Bibliothèque de documents.

Consulter la Bibliothèque de documents

Les clients ont également consulté

Slide 1 of 1

1 of 1

Hydroxyde de sodium BioXtra, ≥98% (acidimetric), pellets (anhydrous)

Sigma-Aldrich

S8045

Hydroxyde de sodium

M Y Hyun et al.
Clinical and experimental dermatology, 40(2), 129-135 (2014-10-17)
Hyaluronic acid (HA) fillers and poly-L-lactic acid (PLA) fillers are frequently used to correct facial wrinkles. To compare the efficacy and safety of a novel injectable poly-L-lactic acid (PLA) filler and a well-studied biphasic HA filler for the treatment of
Elena I Gubanova et al.
Journal of drugs in dermatology : JDD, 14(3), 288-298 (2015-03-05)
In this evaluator-blind, placebo-controlled study, microinjections of stabilized hyaluronic acid (HA) gel for rejuvenation of aging hands were evaluated. Patients received three injections of 1.0 ml HA gel (20 mg/ml HA) in the dorsum of one hand and 1.0 ml
Hee Jung Lee et al.
The Journal of dermatological treatment, 26(1), 73-77 (2014-02-12)
Intense focused ultrasound (IFUS) has been used successfully for skin tightening. To investigate the efficacy of IFUS in treating enlarged pores and to evaluate changes in skin elasticity and sebum production following IFUS. Twenty-two subjects with enlarged pores were randomized
Murad Alam et al.
JAMA dermatology, 150(8), 844-849 (2014-06-13)
Neocollagenesis can be achieved using a dermal rolling needle device, thereby reducing the appearance of acne scars. To determine the efficacy of a needling device for treatment of acne scars. We performed a single-center, rater-blinded, balanced (1:1), split-face, placebo-controlled, parallel-group
Adam Rish
Journal of cosmetic dermatology, 13(4), 253-260 (2014-11-18)
A review of 242 facial treatments, in 86 different patients, with polyacrylamide gel (PAAG) was carried out by the author between 2003 and 2013. To evaluate by retrospective study the long-term outcomes of PAAG filling for facial contouring. To quantify
Afficher tous les articles scientifiques apparentés

Notre équipe de scientifiques dispose d'une expérience dans tous les secteurs de la recherche, notamment en sciences de la vie, science des matériaux, synthèse chimique, chromatographie, analyse et dans de nombreux autres domaines..

Contacter notre Service technique